Skip to content
Round-UpReport

PMCB

PharmaCyte Biotech, Inc.

1-for-19 reverse split, effective Nov 12, 2026.

Ratio
1-for-19
Effective date
Nov 12, 2026
Split-adjusted trading
Nov 13, 2026
Last day to buy
Not clear from the filing

Shown only when the effective date is also when split-adjusted trading begins. Prior NYSE session. Calculated, not a filing field.

Be on record by
Filing does not state a record date
Fractional shares
Cash in lieu
Form
8-K

Filed Nov 13, 2026

…ging those certificates for shares held electronically in book-entry form or for new certificates, in either case representing the post-split number of shares, and any payments in cash in lieu of fractional shares, if applicable.

From the filing, on fractional shares.

Read the SEC filing

Broker reports

No approved reports yet. If your broker handled this split, send a report.

New round-up filings and broker reports. Unsubscribe any time.